Cocrystal Pharma (COCP) Non-Current Debt (2010 - 2013)
Cocrystal Pharma (COCP) posted Non-Current Debt of $2.9 million for Q3 2013, up 0.97% sequentially from $2.9 million in Q2 2013, and up 0.56% YoY from $2.9 million in Q3 2012.
Cocrystal Pharma (COCP) Non-Current Debt (2010 - 2013) Analysis & Trends
Cocrystal Pharma has reported Non-Current Debt for 4 years, with the latest figure at $2.9 million in Q3 2013.
- Quarterly Non-Current Debt rose 0.56% year-over-year to $2.9 million in Q3 2013, while the trailing twelve-month figure through Sep 2013 was $2.9 million (up 0.56% YoY) and the FY2012 annual result came in at $3.1 million, down 6.73% from the prior year.
- Non-Current Debt advanced to $2.9 million in Q3 2013 per COCP's latest filing, from $2.9 million in the prior quarter.
- Over five years, Non-Current Debt peaked at $3.3 million in Q4 2011 and troughed at $2.9 million in Q2 2013.
- A 4-year average of $3.1 million and a median of $3.1 million in 2012 frame the typical range for Non-Current Debt.
- The sharpest annual moves came in 2011 and 2013: Non-Current Debt grew 8.35% in 2011, then retreated 8.52% in 2013.
- Over 4 years, Non-Current Debt stood at $3.0 million in 2010, then rose by 8.35% to $3.3 million in 2011, then slipped by 6.73% to $3.1 million in 2012, then retreated by 4.77% to $2.9 million in 2013.
- According to Business Quant data, Non-Current Debt over the past three periods registered $2.9 million, $2.9 million, and $3.2 million for Q3 2013, Q2 2013, and Q1 2013 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.80 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.53 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 65.33 Bn | 60.14 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.76 Bn | 54.62 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | 882.16 Mn |
| 6 | Alnylam Pharmaceuticals | 31.84 Bn | 28.53 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.23 Bn | 9.84 Bn | 668.28 Mn | 360.97 Mn |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.46 Bn | - | 8.96 Bn |
| 10 | Cocrystal Pharma | 16.27 Mn | 13.95 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2013 | 2.93 Mn |
| Jun 30, 2013 | 2.90 Mn |
| Mar 31, 2013 | 3.16 Mn |
| Dec 31, 2012 | 3.08 Mn |
| Sep 30, 2012 | 2.91 Mn |
| Jun 30, 2012 | 3.17 Mn |
| Mar 31, 2012 | 3.00 Mn |
| Dec 31, 2011 | 3.30 Mn |
| Sep 30, 2011 | 3.09 Mn |
| Jun 30, 2011 | 3.21 Mn |
| Dec 31, 2010 | 3.04 Mn |